Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allisartan Isoproxil versus amlodipine for vascular endothelial function in essential hypertension
ChiCTR1900026297Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allisartan isoproxil and amlodipine in essential hypertension (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Vascular endothelial function. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
allisartan isoproxilamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR1900026297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026297.